Market Cap ₹63 Cr.
Stock P/E 0.0
P/B 2.7
Current Price ₹156.8
Book Value ₹ 57.5
Face Value 10
52W High ₹165
Dividend Yield 0%
52W Low ₹ 130
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) |
---|
Net Sales |
Other Income |
Total Income |
Total Expenditure |
Operating Profit |
Interest |
Depreciation |
Exceptional Income / Expenses |
Profit Before Tax |
Provision for Tax |
Profit After Tax |
Adjustments |
Profit After Adjustments |
Adjusted Earnings Per Share |
#(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|---|---|---|---|---|
Net Sales | 15 | 13 | 18 | 21 | |
Other Income | 0 | 0 | 0 | 0 | |
Total Income | 15 | 13 | 18 | 21 | |
Total Expenditure | 12 | 11 | 16 | 18 | |
Operating Profit | 3 | 2 | 2 | 3 | |
Interest | 0 | 0 | 0 | 0 | |
Depreciation | 1 | 1 | 1 | 1 | |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | |
Profit Before Tax | 2 | 1 | 1 | 2 | |
Provision for Tax | 1 | 0 | 0 | 1 | |
Profit After Tax | 1 | 1 | 1 | 2 | |
Adjustments | 0 | 0 | 0 | 0 | |
Profit After Adjustments | 1 | 1 | 1 | 2 | |
Adjusted Earnings Per Share | 4 | 2.3 | 2.8 | 5.2 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 17% | 12% | 0% | 0% |
Operating Profit CAGR | 50% | 0% | 0% | 0% |
PAT CAGR | 100% | 26% | 0% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | NA% | NA% | NA% | NA% |
ROE Average | 16% | 12% | 13% | 13% |
ROCE Average | 21% | 15% | 16% | 16% |
#(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|
Shareholder's Funds | 8 | 9 | 10 | 12 |
Minority's Interest | 0 | 0 | 0 | 0 |
Borrowings | 2 | 1 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 |
Total Current Liabilities | 4 | 4 | 4 | 4 |
Total Liabilities | 15 | 14 | 15 | 17 |
Fixed Assets | 8 | 8 | 7 | 7 |
Other Non-Current Assets | 0 | 0 | 0 | 1 |
Total Current Assets | 7 | 6 | 8 | 8 |
Total Assets | 15 | 14 | 15 | 17 |
#(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|
Opening Cash & Cash Equivalents | 1 | 1 | 0 | 0 |
Cash Flow from Operating Activities | 2 | 2 | 1 | 3 |
Cash Flow from Investing Activities | -0 | -1 | -0 | -2 |
Cash Flow from Financing Activities | -2 | -2 | -1 | -1 |
Net Cash Inflow / Outflow | -0 | -1 | -0 | 0 |
Closing Cash & Cash Equivalent | 1 | 0 | 0 | 0 |
# | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|
Earnings Per Share (Rs) | 4.01 | 2.31 | 2.84 | 5.17 |
CEPS(Rs) | 6.9 | 5.09 | 5.43 | 7.69 |
DPS(Rs) | 0 | 0 | 0 | 0 |
Book NAV/Share(Rs) | 25 | 27.3 | 30.14 | 35.31 |
Core EBITDA Margin(%) | 19.77 | 16.63 | 11.76 | 15.26 |
EBIT Margin(%) | 15.51 | 9.89 | 8.11 | 12.19 |
Pre Tax Margin(%) | 12.66 | 7.87 | 7.14 | 11.67 |
PAT Margin (%) | 8.79 | 5.75 | 5.14 | 8.24 |
Cash Profit Margin (%) | 15.14 | 12.67 | 9.82 | 12.26 |
ROA(%) | 9.05 | 5.29 | 6.45 | 10.85 |
ROE(%) | 16.03 | 8.82 | 9.89 | 15.79 |
ROCE(%) | 19.42 | 11.3 | 12.94 | 20.79 |
Receivable days | 84.07 | 103.35 | 81.51 | 76.4 |
Inventory Days | 41.54 | 50.63 | 51.09 | 51.66 |
Payable days | 48.86 | 71.46 | 60.58 | 63.5 |
PER(x) | 0 | 0 | 0 | 0 |
Price/Book(x) | 0 | 0 | 0 | 0 |
Dividend Yield(%) | 0 | 0 | 0 | 0 |
EV/Net Sales(x) | 0.23 | 0.18 | 0.11 | 0.2 |
EV/Core EBITDA(x) | 1.07 | 1.1 | 0.87 | 1.23 |
Net Sales Growth(%) | 0 | -11.9 | 37.61 | 13.51 |
EBIT Growth(%) | 0 | -43.85 | 12.85 | 70.7 |
PAT Growth(%) | 0 | -42.41 | 23.1 | 81.95 |
EPS Growth(%) | 0 | -42.41 | 23.1 | 81.95 |
Debt/Equity(x) | 0.46 | 0.24 | 0.17 | 0.08 |
Current Ratio(x) | 1.78 | 1.74 | 1.84 | 2.03 |
Quick Ratio(x) | 1.31 | 1.2 | 1.08 | 1.38 |
Interest Cover(x) | 5.44 | 4.9 | 8.43 | 23.43 |
Total Debt/Mcap(x) | 0 | 0 | 0 | 0 |
# | Sep 2023 | Mar 2024 |
---|---|---|
Promoter | 72.45 | 72.45 |
FII | 0 | 0 |
DII | 0 | 0 |
Public | 27.55 | 27.55 |
Others | 0 | 0 |
Total | 100 | 100 |
# | Sep 2023 | Mar 2024 |
---|---|---|
Promoter | 0.29 | 0.29 |
FII | 0 | 0 |
DII | 0 | 0 |
Public | 0.11 | 0.11 |
Others | 0 | 0 |
Total | 0.4 | 0.4 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About